Introduction
The Pre-Hospital Emergency Care Council (PHECC) has designed new education and training modules to offer appropriate training to existing and new responders who wish to avail of PHECC certified training in 6 medications as listed. This has been possible by SI No. 449 of 2015 Medicinal Products (Prescription and Control of Supply) (Amendment) (No. 2) Regulations 2015 and PHECC clinical practice guidelines (CPGs).
In 2018, these Regulations were amended by SI No. 530 of 2018 Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations 2018. In the 2018 Regulations, the Eighth and Tenth Schedules updated the entries for Naloxone injection by the insertion of ‘Naloxone Nasal Spray’. As a result, PHECC amended the education and training standard (STN022) to accommodate the nasal administration of Naloxone (hydrochloride dihydrate 1.8mg) nasal spray for the emergency treatment of respiratory depression secondary to known or suspected narcotic overdose in accordance with PHECC CPGs.
Table of Medicinal Products
Module ref Medicinal Products
(Tenth schedule; SI 449 of 205 & SI 530 of 2018)
|
STN002-1 |
Epinephrine (adrenaline) |
|
STN002-2 |
Glucagon 1 mg vial and solution (by IM injection) |
|
STN002-3 |
Glyceryl trinitrate Metered dose 0.4mg (by sublingual spray) |
|
STN002-4 |
Naloxone 1mg/ml pre-filled injection (by pre-filled IM injection) Naloxone 1.8 mg nasal spray solution (by nasal administration) |
|
STN002-5 |
Salbutamol 100 mcg multi dose inhaler (by oral inhalation) |
|
STN002-6 |
Medical gas 50% nitrous oxide and 50% oxygen (by inhalation) |
website by Brighton-SEO.co.uk
Please share our content on social media
© 2026 First aid for life LTD. All Rights Reserved.
+353 (0)45 866 117
